Gynecologic Oncology Reports (Dec 2023)

Response of low HER2-expressing ovarian carcinosarcoma to trastuzumab deruxtecan, a case report

  • Peter G. Rose

DOI
https://doi.org/10.1016/j.gore.2023.101311
Journal volume & issue
Vol. 50
p. 101311

Abstract

Read online

No abstracts available.